Kudo, Takamasa
Meireles, Ana M.
Moncada, Reuben
Chen, Yushu
Wu, Ping
Gould, Joshua
Hu, Xiaoyu
Kornfeld, Opher
Jesudason, Rajiv
Foo, Conrad
Höckendorf, Burkhard
Corrada Bravo, Hector
Town, Jason P.
Wei, Runmin
Rios, Antonio https://orcid.org/0000-0002-6717-2267
Chandrasekar, Vineethkrishna
Heinlein, Melanie https://orcid.org/0000-0001-6194-7159
Chuong, Amy S.
Cai, Shuangyi
Lu, Cherry Sakura
Coelho, Paula https://orcid.org/0000-0002-7006-4523
Mis, Monika
Celen, Cemre
Kljavin, Noelyn
Jiang, Jian
Richmond, David
Thakore, Pratiksha
Benito-Gutiérrez, Elia
Geiger-Schuller, Kathryn
Hleap, Jose Sergio https://orcid.org/0000-0003-2602-5276
Kayagaki, Nobuhiko
de Sousa e Melo, Felipe https://orcid.org/0000-0002-9558-3098
McGinnis, Lisa
Li, Bo https://orcid.org/0000-0003-0668-1620
Singh, Avtar
Garraway, Levi
Rozenblatt-Rosen, Orit
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Lubeck, Eric https://orcid.org/0000-0002-5457-0258
Article History
Received: 18 December 2023
Accepted: 20 August 2024
First Online: 7 October 2024
Change Date: 26 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-025-02602-2
Competing interests
: Genentech has submitted a provisional patent application that is based on the technology described in this manuscript. All authors are or were employed by Genentech, Inc., South San Francisco, California, at the time of their contribution to this work. A.R. is a cofounder and equity holder of Celsius Therapeutics and an equity holder in Immunitas and, until 31 July 2020, was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. T.K. is a shareholder of Genomelink, Inc. E.L. is an equity holder in insitro, Inc. A.M.M., R.M., Y.C., P.W., J.G., X.H., O.K., R.J., C.F., B.H., H.C.B., J.P.T., R.W., A.S.C., M.M., C.C., N. Kljavin, J.J., D.R., P.T., E.B.-G., K.G.-S., J.S.H., N. Kayagaki, F.d.S.M., L.M., B.L., A.S., L.G., O.R.-R., A.R. and E.L. are equity holders in Roche.